Skip to content

The Standard Operating Procedure and Reference Values of Audiovisual Sexual Stimulation (AVSS) Erection Test

A Study on the Establishment of Standard Operating Procedure and Reference Values of Audiovisual Sexual Stimulation (AVSS) Erection Test

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018577
Enrollment
Unknown
Registered
2018-09-25
Start date
2018-10-10
Completion date
Unknown
Last updated
2018-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Male erectile dysfunction

Interventions

Gold Standard:International Index of Erectile Function-5 (IIEF-5),Nocturnal penile tumescence and rigidity(NPTR),cavernous artery Color Doppler duplex ultrasound (CDDU) ,including oral PDE5 inhibitor
Index&#32
of&#32
Erectile&#32
Function-5&#32
(IIEF-5)&#32
scores,Nocturnal&#32
tumescence&#32
and&#32
rigidity(NPTR)&#32
parameters,cavernous&#32
duplex&#32
ultrasound&#32
(CDDU)&#32

Sponsors

Renji Hospital Affiliated Medical School, Shanghai Jiao Tong University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.ED patients or healthy men aged 18-60 years old, have a stable relationship with a female partner and have completed at least one sexual intercourse over the last 4 weeks; 2.Subjects have complete clinical data record and consent to participate in clinical investigation; 3.ED population presented ED at least 6 months, and 8=IIEF-5=21; 4.Healthy men has no ED complaint and IIEF-5=22.

Exclusion criteria

Exclusion criteria: 1. Subjects had clinically noteworthy penile deformities, pelvic surgery or trauma of perineal region; 2. Subjects with severe diseases (such as unstable angina or any other evidence of recently diagnosed coronary artery disease, diagnosed atherosclerotic plaque formation, congestive heart failure, arrhythmia, significant renal or hepatic dysfunction); 3. Subjects had received long-term pharmacotherapy or an addiction problem (such as narcotic drugs); 4. Other severe chronic diseases.

Design outcomes

Primary

MeasureTime frame
Provocative penile tumescence and rigidity parameters;Nocturnal penile tumescence and rigidity(NPTR) parameters;International Index of Erectile Function-5 (IIEF-5) scores;

Secondary

MeasureTime frame
cavernous artery Color Doppler duplex ultrasound (CDDU) parameters;

Countries

China

Contacts

Public ContactMu-Jun Lu

Renji Hospital Affiliated Medical School, Shanghai Jiao Tong University

lumujun@163.com+86 13020156427

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026